Ning Deng

Company: BridGene Biosciences Inc.
Job title: Director
Seminars:
Covalent Drug Discovery by Chemoproteomics: Deconvolution of Phenotypic Screening Hits Through IMTAC Proteome-Wide, Live-Cell Screening 2:15 pm
Discussing the advantages of IMTAC proteome-wide, live-cell screening to further drug discovery efforts Identification of novel targets with the potential to overcome acquired chemotherapy resistance in high-grade serous ovarian cancerRead more
day: Conference Day 1